Rajeev M. Shah

Director, 10% owner, Septerna, Inc.; 10% owner, Vor Biopharma Inc.; Director, 10% owner, Artiva Biotherapeutics, Inc.; Director, Mineralys Therapeutics, Inc.

Bought, 12 months

$9.0M

Sold, 12 months

$44.6M

Companies

Latest trade

Aug 12, 2026

Companies

Septerna, Inc.Director, 10% owner −$31.7M Vor Biopharma Inc.10% owner −$26.5M Artiva Biotherapeutics, Inc.Director, 10% owner +$0.2M Mineralys Therapeutics, Inc.Director +$8.8M

Trades

SEPN Sold 746,500 shares at $42.50 $31.7M Aug 12

VOR Sold 213 shares at $19.75 $0.0M Jul 16

ARTV Bought 6,552 shares at $8.94 $0.1M Jul 13

ARTV Bought 15,102 shares at $8.97 $0.1M Jul 10

VOR Sold 165,150 shares at $15.77 $2.6M Apr 22

VOR Sold 828 shares at $15.75 $0.0M Apr 10

VOR Sold 135,201 shares at $16.59 $2.2M Apr 9

VOR Sold 484,104 shares at $16.48 $8.0M Apr 8

MLYS Bought 58,300 shares at $24.16 $1.4M Mar 30

MLYS Bought 310,700 shares at $23.67 $7.4M Mar 27

VOR Sold 260,859 shares at $29.39 $7.7M Oct 17

VOR Sold 151,803 shares at $29.45 $4.5M Oct 16

VOR Sold 51,363 shares at $30.55 $1.6M Oct 15

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.